Home Casteddu.com	FAQ My Amedeo About	Flying Publisher
	The Medical Article of the Year 2008: Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007; 447:661-78. Free full-text

Hyperlipoproteinemias

Free Subscription Articles published in Am J Cardiol Retrieve available abstracts of 63 articles: HTML format

Single Articles

May 2008
1. BRASS EP , Vassil T, Replogle A, Hwang P, et al
   Can consumers self-select for appropriate use of an over-the-counter statin? The Self Evaluation of Lovastatin to Enhance Cholesterol Treatment Study.
   Am J Cardiol. 2008;101:1448-55.
   PubMed     Related articles    Abstract available
   
   
   
2. BALLANTYNE CM , Davidson MH, McKenney J, Keller LH, et al
   Comparison of the safety and efficacy of a combination tablet of niacin extended release and simvastatin vs simvastatin monotherapy in patients with increased non-HDL cholesterol (from the SEACOAST I study).
   Am J Cardiol. 2008;101:1428-36.
   PubMed     Related articles    Abstract available
   
   
   
3. ALBERT NM , Birtcher KK, Cannon CP, Goff DC Jr, et al
   Factors Associated With Discharge Lipid-Lowering Drug Prescription in Patients Hospitalized for Coronary Artery Disease (from the Get With the Guidelines Database).
   Am J Cardiol. 2008;101:1242-6.
   PubMed     Related articles    Abstract available
   
   
   April 2008
4. BROWN BG , Zhao XQ
   Nicotinic acid, alone and in combinations, for reduction of cardiovascular risk.
   Am J Cardiol. 2008;101.
   PubMed     Related articles    Abstract available
   
   
   
5. KNOPP RH , Paramsothy P, Atkinson B, Dowdy A, et al
   Comprehensive lipid management versus aggressive low-density lipoprotein lowering to reduce cardiovascular risk.
   Am J Cardiol. 2008;101.
   PubMed     Related articles    Abstract available
   
   
   
6. SCANU AM , Bamba R
   Niacin and lipoprotein(a): facts, uncertainties, and clinical considerations.
   Am J Cardiol. 2008;101.
   PubMed     Related articles    Abstract available
   
   
   
7. BARAC A , Campia U, Matuskey LA, Lu L, et al
   Effects of peroxisome proliferator-activated receptor-gamma activation with pioglitazone on plasma adipokines in nondiabetic patients with either hypercholesterolemia or hypertension.
   Am J Cardiol. 2008;101:980-5.
   PubMed     Related articles    Abstract available
   
   
   February 2008
8. KAPOOR JR
   Postprandial hyperglycemia: are all sulfonylureas created equal?
   Am J Cardiol. 2008;101:554-5.
   PubMed     Related articles   
   
   
   
9. ATHYROS VG , Tziomalos K, Kakafika AI, Koumaras H, et al
   Effectiveness of ezetimibe alone or in combination with twice a week Atorvastatin (10 mg) for statin intolerant high-risk patients.
   Am J Cardiol. 2008;101:483-5.
   PubMed     Related articles    Abstract available
   
   
   
10. AI M , Otokozawa S, Asztalos BF, Nakajima K, et al
    Effects of maximal doses of atorvastatin versus rosuvastatin on small dense low-density lipoprotein cholesterol levels.
    Am J Cardiol. 2008;101:315-8.
    PubMed     Related articles    Abstract available
    
    
    December 2007
11. EHARA S , Naruko T, Kobayashi Y, Kataoka T, et al
    Comparison of clinical characteristics and arterial remodeling by intravascular ultrasonic imaging in three age groups (</=55, 56 to 69 and >/=70 years) of Japanese patients with acute myocardial infarction.
    Am J Cardiol. 2007;100:1713-7.
    PubMed     Related articles    Abstract available
    
    
    November 2007
12. ALSHEIKH-ALI AA , Lin JL, Abourjaily P, Ahearn D, et al
    Prevalence of low high-density lipoprotein cholesterol in patients with documented coronary heart disease or risk equivalent and controlled low-density lipoprotein cholesterol.
    Am J Cardiol. 2007;100:1499-501.
    PubMed     Related articles    Abstract available
    
    
    
13. STEIN EA , Amerena J, Ballantyne CM, Brice E, et al
    Long-Term Efficacy and Safety of Rosuvastatin 40 mg in Patients With Severe Hypercholesterolemia.
    Am J Cardiol. 2007;100:1387-96.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
14. OPOLE IO , Belmont JM, Kumar A, Moriarty PM, et al
    Effect of low-density lipoprotein apheresis on inflammatory and noninflammatory high-density lipoprotein cholesterol.
    Am J Cardiol. 2007;100:1416-8.
    PubMed     Related articles    Abstract available
    
    
    October 2007
15. BETTERIDGE DJ , Gibson JM, Sager PT
    Comparison of Effectiveness of Rosuvastatin Versus Atorvastatin on the Achievement of Combined C-Reactive Protein (<2 mg/L) and Low-Density Lipoprotein Cholesterol (<70 mg/dl) Targets in Patients With Type 2 Diabetes Mellitus (from the ANDROMEDA St
    Am J Cardiol. 2007;100:1245-8.
    PubMed     Related articles    Abstract available
    
    
    
16. YE ZX , Cheng HM, Chiou KR, Huang PH, et al
    Relation of Coronary Artery Calcium to Flow-Mediated Dilation and C-Reactive Protein Levels in Asymptomatic Patients With Heterozygous Familial Hypercholesterolemia.
    Am J Cardiol. 2007;100:1119-1123.
    PubMed     Related articles    Abstract available
    
    
    September 2007
17. O'KEEFE JH , Bell DS
    Postprandial hyperglycemia/hyperlipidemia (postprandial dysmetabolism) is a cardiovascular risk factor.
    Am J Cardiol. 2007;100:899-904.
    PubMed     Related articles    Abstract available
    
    
    
18. CAMPBELL CY , Nasir K, Sarwar A, Meneghelo RS, et al
    Combined effect of high low-density lipoprotein cholesterol and metabolic syndrome on subclinical coronary atherosclerosis in white men without clinical evidence of myocardial ischemia.
    Am J Cardiol. 2007;100:840-3.
    PubMed     Related articles    Abstract available
    
    
    
19. ZHAO D , Grundy SM, Wang W, Liu J, et al
    Ten-year cardiovascular disease risk of metabolic syndrome without central obesity in middle-aged chinese.
    Am J Cardiol. 2007;100:835-9.
    PubMed     Related articles    Abstract available
    
    
    August 2007
20. KARALIS DG , Ishisaka DY, Luo D, Ntanios F, et al
    Effects of increasing doses of atorvastatin on the atherogenic lipid subclasses commonly associated with hypertriglyceridemia.
    Am J Cardiol. 2007;100:445-9.
    PubMed     Related articles    Abstract available
    
    
    
21. BACKES JM , Moriarty PM, Ruisinger JF, Gibson CA, et al
    Effects of once weekly rosuvastatin among patients with a prior statin intolerance.
    Am J Cardiol. 2007;100:554-5.
    PubMed     Related articles    Abstract available
    
    
    July 2007
22. RAJAGOPALAN S , Zannad F, Radauceanu A, Glazer R, et al
    Effects of valsartan alone versus valsartan/simvastatin combination on ambulatory blood pressure, C-reactive protein, lipoproteins, and monocyte chemoattractant protein-1 in patients with hyperlipidemia and hypertension.
    Am J Cardiol. 2007;100:222-6.
    PubMed     Related articles    Abstract available
    
    
    
23. KOSTIS JB
    Treating hypercholesterolemia and hypertension based on lifetime global risk.
    Am J Cardiol. 2007;100:138-42.
    PubMed     Related articles   
    
    
    June 2007
24. GINSBERG HN , Bonds DE, Lovato LC, Crouse JR, et al
    Evolution of the Lipid Trial Protocol of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial.
    Am J Cardiol. 2007;99.
    PubMed     Related articles    Abstract available
    
    
    
25. GILLESPIE MJ , Davis CJ, Lambert ND, Costello FM, et al
    Measuring and treating serum lipids in patients in a chest pain observation unit.
    Am J Cardiol. 2007;99:1718-20.
    PubMed     Related articles    Abstract available
    
    
    
26. PEARSON T , Ballantyne C, Sisk C, Shah A, et al
    Comparison of effects of ezetimibe/simvastatin versus simvastatin versus atorvastatin in reducing C-reactive protein and low-density lipoprotein cholesterol levels.
    Am J Cardiol. 2007;99:1706-1713.
    PubMed     Related articles    Abstract available
    
    
    
27. FRIEDEWALD VE , Gheorghiade M, Yancy CW, Young JB, et al
    The Editor's Roundtable: Acute Decompensated Heart Failure.
    Am J Cardiol. 2007;99:1560-7.
    PubMed     Related articles   
    
    
    
28. DEEDWANIA PC , Gupta M, Stein M, Ycas J, et al
    Comparison of Rosuvastatin Versus Atorvastatin in South-Asian Patients at Risk of Coronary Heart Disease (from the IRIS Trial).
    Am J Cardiol. 2007;99:1538-43.
    PubMed     Related articles    Abstract available
    
    
    May 2007
29. CASO G , Kelly P, McNurlan MA, Lawson WE, et al
    Effect of coenzyme q10 on myopathic symptoms in patients treated with statins.
    Am J Cardiol. 2007;99:1409-12.
    PubMed     Related articles    Abstract available
    
    
    
30. MAINOUS AG 3RD , Koopman RJ, Diaz VA, Everett CJ, et al
    A coronary heart disease risk score based on patient-reported information.
    Am J Cardiol. 2007;99:1236-41.
    PubMed     Related articles    Abstract available
    
    
    March 2007
31. ASZTALOS BF , Le Maulf F, Dallal GE, Stein E, et al
    Comparison of the effects of high doses of rosuvastatin versus atorvastatin on the subpopulations of high-density lipoproteins.
    Am J Cardiol. 2007;99:681-5.
    PubMed     Related articles    Abstract available
    
    
    
32. BALLANTYNE CM , Weiss R, Moccetti T, Vogt A, et al
    Efficacy and Safety of Rosuvastatin 40 mg Alone or in Combination With Ezetimibe in Patients at High Risk of Cardiovascular Disease (Results from the EXPLORER Study).
    Am J Cardiol. 2007;99:673-80.
    PubMed     Related articles    Abstract available
    
    
    February 2007
33. LLOYD-JONES DM , Dyer AR, Wang R, Daviglus ML, et al
    Risk factor burden in middle age and lifetime risks for cardiovascular and non-cardiovascular death (chicago heart association detection project in industry).
    Am J Cardiol. 2007;99:535-40.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
34. ST-PIERRE J , Lemieux I, Perron P, Brisson D, et al
    Relation of the "hypertriglyceridemic waist" phenotype to earlier manifestations of coronary artery disease in patients with glucose intolerance and type 2 diabetes mellitus.
    Am J Cardiol. 2007;99:369-73.
    PubMed     Related articles    Abstract available
    
    
    January 2007
35. MACKIE BD , Satija S, Nell C, Miller J 3rd, et al
    Monday, Wednesday, and Friday dosing of rosuvastatin in patients previously intolerant to statin therapy.
    Am J Cardiol. 2007;99:291.
    PubMed     Related articles    Abstract available
    
    
    
36. SHAPIRO H , Bruck R
    Omega-3 may indirectly reduce hepatocyte triglycerides through modulation of hyperinsulinemia, cytokines and adipocytokines.
    Am J Cardiol. 2007;99:146.
    PubMed     Related articles   
    
    
    
37. ITO MK , Marrs J, Williams C
    Omacor effects on serum lipids and clinical outcome.
    Am J Cardiol. 2007;99:145.
    PubMed     Related articles   
    
    
    
38. DEFARIA YEH D , Freeman MW, Meigs JB, Grant RW, et al
    Risk factors for coronary artery disease in patients with elevated high-density lipoprotein cholesterol.
    Am J Cardiol. 2007;99:1-4.
    PubMed     Related articles    Abstract available
    
    
    November 2006
39. ROBINSON JG , Stone NJ
    Identifying patients for aggressive cholesterol lowering: the risk curve concept.
    Am J Cardiol. 2006;98:1405-8.
    PubMed     Related articles    Abstract available
    
    
    
40. NAWAZ H , Comerford BP, Njike VY, Dhond AJ, et al
    Repeated serum lipid measurements during the peri-hospitalization period.
    Am J Cardiol. 2006;98:1379-82.
    PubMed     Related articles    Abstract available
    
    
    
41. RAVIPATI G , Aronow WS, Ahn C, Channamsetty V, et al
    Incidence of new stroke or new myocardial infarction or death in patients with severe carotid arterial disease treated with and without statins.
    Am J Cardiol. 2006;98:1170-1.
    PubMed     Related articles    Abstract available
    
    
    October 2006
42. MESSERLI FH , Bangalore S, Egan BM, Julius S, et al
    Does life-long reduction in low-density lipoprotein cholesterol reduce the risk of new-onset hypertension?
    Am J Cardiol. 2006;98:1122.
    PubMed     Related articles   
    
    
    
43. PANZA F , Capurso C, Solfrizzi V
    Cardiovascular factors and cognitive impairment: a role for unsaturated Fatty acids and mediterranean diet?
    Am J Cardiol. 2006;98:1120-1.
    PubMed     Related articles   
    
    
    
44. SAKAI K , Nakagawa Y, Soga Y, Ando K, et al
    Comparison of 30-day outcomes in patients <75 years of age versus >/=75 years of age with acute myocardial infarction treated by primary coronary angioplasty.
    Am J Cardiol. 2006;98:1018-21.
    PubMed     Related articles    Abstract available
    
    
    
45. COOPER-DEHOFF R , Cohen JD, Bakris GL, Messerli FH, et al
    Predictors of Development of Diabetes Mellitus in Patients With Coronary Artery Disease Taking Antihypertensive Medications (Findings from the INternational VErapamil SR-Trandolapril STudy [INVEST]).
    Am J Cardiol. 2006;98:890-4.
    PubMed     Related articles    Abstract available
    
    
    September 2006
46. LLORET R , Ycas J, Stein M, Haffner S, et al
    Comparison of Rosuvastatin Versus Atorvastatin in Hispanic-Americans With Hypercholesterolemia (from the STARSHIP Trial).
    Am J Cardiol. 2006;98:768-73.
    PubMed     Related articles    Abstract available
    
    
    
47. DEVARAJ S , Autret B, Jialal I
    Effects of Colesevelam Hydrochloride (WelChol) on Biomarkers of Inflammation in Patients With Mild Hypercholesterolemia.
    Am J Cardiol. 2006;98:641-3.
    PubMed     Related articles    Abstract available
    
    
    
48. SOROKIN AV , Duncan B, Panetta R, Thompson PD, et al
    Rhabdomyolysis associated with pomegranate juice consumption.
    Am J Cardiol. 2006;98:705-6.
    PubMed     Related articles    Abstract available
    
    
    August 2006
49. BAYS H
    Clinical overview of Omacor: a concentrated formulation of omega-3 polyunsaturated fatty acids.
    Am J Cardiol. 2006;98.
    PubMed     Related articles    Abstract available
    
    
    
50. REIFFEL JA , McDonald A
    Antiarrhythmic effects of omega-3 fatty acids.
    Am J Cardiol. 2006;98.
    PubMed     Related articles    Abstract available
    
    
    
51. SINGH M , Lennon RJ, Roger VL, Rihal CS, et al
    Relation of preprocedural statin therapy to in-hospital procedural complications following percutaneous coronary interventions in patients with hyperlipidemia.
    Am J Cardiol. 2006;98:325-30.
    PubMed     Related articles    Abstract available
    
    
    
52. CHENG TO
    Prevalence of metabolic syndrome in Chinese adults has been underestimated by using US-Based National Cholesterol Education Programs Adult Treatment Panel III and World Health Organization criteria.
    Am J Cardiol. 2006;98:422-3.
    PubMed     Related articles   
    
    
    July 2006
53. WONG ND , Lopez V, Tang S, Williams GR, et al
    Prevalence, treatment, and control of combined hypertension and hypercholesterolemia in the United States.
    Am J Cardiol. 2006;98:204-8.
    PubMed     Related articles    Abstract available
    
    
    
54. MEYERS CD , McCarren M, Wong ND, Abraira C, et al
    Baseline Achievement of Lipid Goals and Usage of Lipid Medications in Patients With Diabetes Mellitus (from the Veterans Affairs Diabetes Trial).
    Am J Cardiol. 2006;98:63-5.
    PubMed     Related articles    Abstract available
    
    
    June 2006
55. KLONER RA , Jackson G, Hutter AM, Mittleman MA, et al
    Cardiovascular Safety Update of Tadalafil: Retrospective Analysis of Data from Placebo-Controlled and Open-Label Clinical Trials of Tadalafil With As Needed, Three Times-per-Week or Once-a-Day Dosing.
    Am J Cardiol. 2006;97:1778-84.
    PubMed     Related articles    Abstract available
    
    
    
56. CROUSE JR 3RD , Elam MB, Robinson JG, Ambrosius WT, et al
    Cholesterol management: targeting a lower low-density lipoprotein cholesterol concentration increases adult treatment panel-III goal attainment.
    Am J Cardiol. 2006;97:1667-9.
    PubMed     Related articles   
    
    
    
57. VIDT DG , Harris S, McTaggart F, Ditmarsch M, et al
    Effect of short-term rosuvastatin treatment on estimated glomerular filtration rate.
    Am J Cardiol. 2006;97:1602-6.
    PubMed     Related articles    Abstract available
    
    
    May 2006
58. RUBINSHTEIN R , Halon DA, Jaffe R, Shahla J, et al
    Relation between obesity and severity of coronary artery disease in patients undergoing coronary angiography.
    Am J Cardiol. 2006;97:1277-80.
    PubMed     Related articles    Abstract available
    
    
    April 2006
59. BAYS HE , Davidson M, Jones MR, Abby SL, et al
    Effects of colesevelam hydrochloride on low-density lipoprotein cholesterol and high-sensitivity C-reactive protein when added to statins in patients with hypercholesterolemia.
    Am J Cardiol. 2006;97:1198-205.
    PubMed     Related articles    Abstract available
    
    
    
60. NASH DT , Fillit H
    Cardiovascular disease risk factors and cognitive impairment.
    Am J Cardiol. 2006;97:1262-5.
    PubMed     Related articles    Abstract available
    
    
    
61. TANEVA E , Borucki K, Wiens L, Makarova R, et al
    Early effects on endothelial function of atorvastatin 40 mg twice daily and its withdrawal.
    Am J Cardiol. 2006;97:1002-6.
    PubMed     Related articles    Abstract available
    
    
    March 2006
62. WOJNICZ R , Wilczek K, Nowalany-Kozielska E, Szygula-Jurkiewicz B, et al
    Usefulness of atorvastatin in patients with heart failure due to inflammatory dilated cardiomyopathy and elevated cholesterol levels.
    Am J Cardiol. 2006;97:899-904.
    PubMed     Related articles    Abstract available
    
    
    
63. SIMON JA , Lin F, Hulley SB, Blanche PJ, et al
    Phenotypic predictors of response to simvastatin therapy among African-Americans and Caucasians: the Cholesterol and Pharmacogenetics (CAP) Study.
    Am J Cardiol. 2006;97:843-50.
    PubMed     Related articles    Abstract available
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Bernd Sebastian Kamps website.    Design: